ArticleBMC cancer2016

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report.

Andrea Casadei Gardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.